These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 19450335)
1. NHL (diffuse large B cell lymphoma). Kyle F; Hill M BMJ Clin Evid; 2008 Jan; 2008():. PubMed ID: 19450335 [TBL] [Abstract][Full Text] [Related]
2. NHL (diffuse large B-cell lymphoma). Hill M; Kyle F BMJ Clin Evid; 2010 Nov; 2010():. PubMed ID: 21406125 [TBL] [Abstract][Full Text] [Related]
3. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Plosker GL; Figgitt DP Drugs; 2003; 63(8):803-43. PubMed ID: 12662126 [TBL] [Abstract][Full Text] [Related]
6. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma]. Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686 [TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer treatment. Qureshi A; Verma A; Ross P; Landau D BMJ Clin Evid; 2010 Apr; 2010():. PubMed ID: 21718569 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol]. Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405 [TBL] [Abstract][Full Text] [Related]
12. A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study. Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP Ann Oncol; 1994; 5 Suppl 2():91-5. PubMed ID: 7515652 [TBL] [Abstract][Full Text] [Related]
13. Cyclophosphamide, doxorubicin, vincristine, and prednisone versus intensive chemotherapy in non-Hodgkin's lymphoma. Fisher RI Cancer Chemother Pharmacol; 1997; 40 Suppl():S42-6. PubMed ID: 9272133 [TBL] [Abstract][Full Text] [Related]
16. Immunochemotherapy: the new standard in aggressive non-Hodgkin's lymphoma in the elderly. Coiffier B Semin Oncol; 2003 Feb; 30(1 Suppl 2):21-7. PubMed ID: 12652461 [TBL] [Abstract][Full Text] [Related]